Related content

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

By Joseph Richard W.   Kapur Payal   Serie Daniel J.   Eckel-Passow Jeanette E.   Parasramka Mansi   Ho Thai   Cheville John C.   Frenkel Eugene   Rakheja Dinesh   Brugarolas James   Parker Alexander  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 1059-1067

Blackwell Publishing

Access to resources Recommend Favorite

Evaluation of Plasma and Tissue S100A4 Protein and mRNA Levels as Potential Markers of Metastasis and Prognosis in Clear Cell Renal Cell Carcinoma

By Yang H   Zhao K   Yu Q   Wang X   Song Y   Li R  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 475-485

Field House Publishing

Access to resources Recommend Favorite

High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis

By Zhang Dong-Hong   Chen Jiong-Yu   Hong Chao-Qun   Yi De-Qing   Wang Fei   Cui Wei  

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2673-2683

Blackwell Publishing

Access to resources Recommend Favorite

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3435-3443

Blackwell Publishing

Access to resources Recommend Favorite

Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma

By Haddad Ahmed Q.   Kapur Payal   Singla Nirmish   Raman Jay D.   Then Matthew T.   Nuhn Philipp   Buchner Alexander   Bastian Patrick   Seitz Christian   Shariat Shahrokh F.   Bensalah Karim   Rioux-Leclercq Nathalie   Sagalowsky Arthur   Lotan Yair   Margulis Vitaly  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 43-50

Blackwell Publishing

Access to resources Recommend Favorite